Skip to main content
. Author manuscript; available in PMC: 2011 Dec 14.
Published in final edited form as: Environ Res. 2008 Aug 21;108(3):393–399. doi: 10.1016/j.envres.2008.07.003

Table 7.

Creatinine-adjusted urinary albumin by treatment group for creatinine > 30 mg/gm creatinine.

Albumin/creatinine > 30 during follow up
Age Amalgam
events / visits
Composite
events / visits
Odds Ratio
(amal/comp)
p-value
9 3 / 32 5 / 37 0.7 0.72
10 4 / 95 13 / 107 0.3 0.52
11 12 / 182 15 / 178 0.8 0.69
12 21 / 231 26 / 230 0.8 0.67
13 33 / 235 37 / 229 0.8 0.70
14 22 / 206 26 / 224 0.9 0.78
15 18 / 197 33 / 211 0.5 0.52
16 17 / 158 17 / 132 0.8 0.72
17 14 / 103 8 / 83 1.5 0.66
18 3 / 30 3 / 29 1.0 0.83

Wald tests were used to test for a difference in the log odds of albumin/creatinine > 30 (odds ratio different from 1) at each age during follow-up.